This Lancashire firm recruits patients and conducts clinical trials for pharmaceutical and research organisations. Following a string of acquisitions, it now operates 25 research centres across Britain, Germany, Eastern Europe and South Africa, and had international sales of £23.4m last year. Led by chief executive Christophe Berthoux, 53, Synexus plans to expand into the US, Asia and South America, after private equity firm LDC invested in an £83m secondary buyout in February.
This profile reflects the company at time of publication and does not reflect any changes that may have subsequently occurred. Fast Track and its sponsors do not endorse, guarantee or recommend investment in any of the companies.